Green Medi Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Green Medi Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parveen Singhal and Ashish Goyal serve as directors at the Company.
- CIN/LLPIN
U01100UP2020PTC128916
- Company No.
128916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Green Medi Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Singhal  | Director | 31-May-2020 | Current |
| Ashish Goyal | Director | 31-May-2020 | Current |
Financial Performance and Corporate Structure Insights of Green Medi Biotech.
Enhance accessibility to Green Medi Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Green Medi Biotech?
Unlock access to Green Medi Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
V I P Handlooms Private LimitedActive 26 years 8 monthsParveen Singhal and Ashish Goyal are mutual person
- Alps Pharmaceuticals Private LimitedActive 44 years 8 months
Parveen Singhal and Ashish Goyal are mutual person
- Northern Erectors Private LimitedActive 38 years 6 months
Parveen Singhal and Ashish Goyal are mutual person
- Ghaziabad Infrastructures Private LimitedActive 10 years 10 months
Parveen Singhal and Ashish Goyal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Medi Biotech?
Green Medi Biotech has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Medi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Medi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.